Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Nicoletto MO"'
Autor:
du Bois, A, Kristensen, G, Ray-Coquard, I, Reuss, A, Pignata, S, Colombo, N, Denison, U, Vergote, I, Del Campo JM, Ottevanger, P, Heubner, M, Minarik, T, Sevin, E, de Gregorio, N, Bidziński, M, Pfisterer, J, Malander, S, Hilpert, F, Mirza, Mr, Scambia, G, Meier, W, Nicoletto, Mo, Bjørge, L, Lortholary, A, Sailer, Mo, Merger, M, Harter, P, AGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup Consortium: Università degli Studi di Torino ITA, Ferrero, A, Et, Al
Publikováno v:
Lancet Oncology, 17, 1, pp. 78-89
du Bois, A, Kristensen, G, Ray-Coquard, I, Reuss, A, Pignata, S, Colombo, N, Denison, U, Vergote, I, Del Campo, J M, Ottevanger, P, Heubner, M, Minarik, T, Sevin, E, de Gregorio, N, Bidziński, M, Pfisterer, J, Malander, S, Hilpert, F, Mirza, M R, Scambia, G, Meier, W, Nicoletto, M O, Bjørge, L, Lortholary, A, Sailer, M O, Merger, M, Harter, P & AGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup Consortium 2016, ' Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12) : a randomised, double-blind, placebo-controlled phase 3 trial ', Lancet Oncology, vol. 17, no. 1, pp. 78-89 . https://doi.org/10.1016/S1470-2045(15)00366-6
Lancet Oncology, 17, 78-89
du Bois, A, Kristensen, G, Ray-Coquard, I, Reuss, A, Pignata, S, Colombo, N, Denison, U, Vergote, I, Del Campo, J M, Ottevanger, P, Heubner, M, Minarik, T, Sevin, E, de Gregorio, N, Bidziński, M, Pfisterer, J, Malander, S, Hilpert, F, Mirza, M R, Scambia, G, Meier, W, Nicoletto, M O, Bjørge, L, Lortholary, A, Sailer, M O, Merger, M, Harter, P & AGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup Consortium 2016, ' Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12) : a randomised, double-blind, placebo-controlled phase 3 trial ', Lancet Oncology, vol. 17, no. 1, pp. 78-89 . https://doi.org/10.1016/S1470-2045(15)00366-6
Lancet Oncology, 17, 78-89
BACKGROUND: Angiogenesis is a target in the treatment of ovarian cancer. Nintedanib, an oral triple angiokinase inhibitor of VEGF receptor, platelet-derived growth factor receptor, and fibroblast growth factor receptor, has shown activity in phase 2
Autor:
Fridley, BL, Goode, EL, Høgdall, E, Jensen, A, Cass, I, Kjær, SK, Johnatty, SE, Nicoletto, MO, D'Andrea, E, Montagna, M, Blanco, I, Lázaro, C, Ma, ESK, Daly, MB, Godwin, AK, Eeles, R, Evans, DG, Frost, D, Peock, S, Hartge, P, Gail, MH, Neuhausen, S, García, MJ, Benítez, J, Sinilnikova, O, Easton, DF, Healey, S, McGuffog, L, Barrowdale, D, Despierre, E, Lambrechts, D, Karlan, BY, Ramus, SJ, Sadetzki, S, Goh, C, ChenevixTrench, G, Bolton, KL, Li, AJ, Walsh, C, Gross, J, Steele, L, Beattie, MS, Chan, S, Nussbaum, RL, Moysich, KB, Leuchter, R, Borg, Å, Olsson, H, Kristoffersson, U, Sieh, W, McGuire, V, Whittemore, AS, Tyrer, J, Song, H, Michie, CO, Gourley, C, Gore, ME, Senter, L, Toland, AE, Glendon, G, HirshYechezkel, G, Lubin, F, Chetrit, A, Mai, PL, Greene, MH, Loud, JT, Levine, DA, Gordon, O, GarciaClosas, M, Gayther, SA, Chanock, SJ, Antoniou, AC, Pharoah, PDP, Andrulis, IL, Kwong, A
Context: Approximately 10% of women with invasive epithelial ovarian cancer (EOC) carry deleterious germline mutations in BRCA1 or BRCA2. A recent article suggested that BRCA2-related EOC was associated with an improved prognosis, but the effect of B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______961::26300e4c4ad8b29c56279357f406856d
http://hdl.handle.net/10722/182264
http://hdl.handle.net/10722/182264
Autor:
Nicoletto, Mo, Borgato, L, Artioli, G, Perin, A, Zustovich, F, Ghiotto, C, Koussic, H, Cappetta, A, Mocellin, S, Furini, L, Dalla Palma, M, Ercoli, A, Litta, PIETRO SALVATORE, Nardelli, GIOVANNI BATTISTA, Zagonel, V.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3657::0f4bc933c066249287a1c8edc8da3f4f
http://hdl.handle.net/11577/2484624
http://hdl.handle.net/11577/2484624
Autor:
Agnelli, G, Gussoni, G, Bianchini, C, Verso, M, Mandalà, M, Cavanna, L, Barni, S, Labianca, R, Buzzi, F, Scambia, G, Passalacqua, R, Ricci, S, Gasparini, G, Lorusso, V, Bonizzoni, E, Tonato, M, PROTECHT Investigators Agnelli, G, Amadori, D, Barbui, T, Cognetti, F, Crinò, L, Mannucci, Pm, Moia, M, Gianni, L, Prandoni, P, Cesana, B, de Braud, F, Del Favero, A, Lazzaro, A, Anselmi, E, Mordenti, P, Cabiddu, M, Petrelli, F, Ghilardi, M, Poletti, P, Marelli, B, Fumagalli, D, Sabatini, S, Fumi, G, Masi, C, Salutari, V, Malaggese, M, Brighenti, M, Lazzarelli, S, Donati, G, Di Donato, S, Arrighi, G, Orlandini, C, Amici, S, Verì, A, Sarmento, R, Pollera, C, Capomolla, E, Moschetti, L, Garufi, C, Campanella, C, Torsello, A, Misino, A, Ciuffreda, L, Dongiovanni, V, Addeo, A, Vitale, Fv, Ferraù, F, Priolo, D, Muggiano, A, Mulas, C, Tedde, A, Pogliani, Ea, Ardizzoia, A, Villa, F, Montedoro, M, Bravi, S, Biagioni, F, Palazzo, S, Filice, A, Gori, S, Porrozzi, S, Ciccarese, M, Petrucelli, L, Chiuri, Ve, Passardi, A, Ravaioli, E, Ceravolo, R, Crivellari, G, Nicoletto, Mo, Brandes, A, Bertolini, S, Benedetti, G, Bernardo, G, Teragni, C, Jirillo, A, Falci, C, Santoro, A, Masci, G, Monti, M, Casanova, C, Intrivici, C, Rinaldi, G, Massidda, B, Ionta, Mt, Dogliotti, Luigi, Russo, L, Collovà, E, Luoni, M, Maiello, E, Romano, Mp, Molica, S, Battaglia, C, Doni, L, Di Costanzo, F, Giuliodori, L, Silva, Rr, Sarobba, Mg, Pinna, A, Sorarù, M, Gaion, F, Ferrandina, G, Gilli, G, Locatelli, Mc, Zanaboni, F, Bologna, A, Ferretti, G, Chini, C, Farina, G, Bronner, L, Biscottini, B, Tomirotti, M, Sciacca, V.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______970::b1bace0cd8d0c9def239ba441fcd5820
http://hdl.handle.net/2318/83869
http://hdl.handle.net/2318/83869
Autor:
Nicoletto, Mo, Caltarossa, E, Donach, M, Nardelli, GIOVANNI BATTISTA, Parenti, ANNA ROSITA, Ambrosini, Antonio
Publikováno v:
European journal of gynaecological oncology. 27(1)
Sertoli-Leydig cell tumors constitute1% of ovarian tumors, mostly in young women with virilization; however, not all present endocrine manifestations. A 72-year-old female presented with an abdominal mass and no signs of virilization. Total abdominal
Autor:
Plebani, Mario, Navaglia, F, Basso, Daniela, De Paoli, M, Nicoletto, Mo, Maraglino, E, Torre, Gc
Publikováno v:
Anticancer research. 16(6B)
UGP, the beta-core fragment of human chorionic gonadotropin has been proposed as a tumor marker for gynecological malignancies. This fragment may be detected in a single morning-specimen of urine using an enzyme immunoassay. In this study, the diagno
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.